AdvaMed® Tariff Talking Points
Essential advocacy insights on how new tariffs impact the MedTech industry. Use these key messages when engaging with policymakers, industry stakeholders, and media.
Global & Trade
Learn more about our Global Affairs work.
FAQs: President Trump’s Tariffs on Mexico, Canada, and China
Get clear answers on the scope, impact, and implementation of tariffs on key U.S. trade partners. These FAQs explains tariff rates, exemptions, economic implications, and potential retaliatory actions.
AdvaMed® Seeks Medical Technology Exemption from All Tariffs
AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
Key Congressional Dates
A timeline of critical policy and legislative deadlines, including budget resolutions, trade discussions, and key votes that may impact MedTech and global trade policies.
EY 18th annual Pulse of the MedTech Industry Report
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for…
AdvaMed® Welcomes India, New Member Countries from Latin America, Middle East, Africa to IMDRF
The International Medical Device Regulators Forum (IMDRF) consists of medical device regulators from around the world that voluntarily convene to harmonize the regulatory requirements for medical products varying from country to…
AdvaMed® Welcomes APEC Recommendations for Enterprise Integrity and Public Procurement
Lima, Peru – AdvaMed, The Medtech Association®, issued the following press release following conclusion of the 2024 Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized Enterprises (SMEs) Forum in…
AdvaMed® Signs New MOU with British Medtech Association
AdvaMed, The Medtech Association®, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in…
AdvaMed® Statement on FDA-USAID India Regulatory Session
AdvaMed, The Medtech Association®, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
AdvaMed® Statement on the World Trade Organization Ministerial Conference
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.